Gideon Pharmaceuticals, Inc.
Records under this name other than patents Gideon Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 3 of 3 · Back to Gideon Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,238,017 | Compositions with reduced hepatotoxicity Formerly held Term ended Term ended Sep 25, 2024 · USPTO record | Term ended | Term ended Sep 25, 2024 | USPTO record |
| US 7,772,275 | Compositions and method for treating affective, painful or allergic disorders Formerly held Term ended Ended no later than Nov 14, 2022 · USPTO record | Term ended | Ended no later than Nov 14, 2022 | USPTO record |
| US 7,629,378 | Compositions and method for treating affective, painful or allergic disorders Formerly held Lapsed on the fee record Ended Dec 8, 2021 · USPTO record | Lapsed on the fee record | Ended Dec 8, 2021 | USPTO record |